4//SEC Filing
Prince Joshua S. 4
Accession 0001998663-26-000002
CIK 0001411685other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 8:51 PM ET
Size
4.9 KB
Accession
0001998663-26-000002
Insider Transaction Report
Form 4
Prince Joshua S.
Chief Operating Officer
Transactions
- Award
Common Stock
2025-12-31$0.56/sh+4,386$2,468→ 15,249 total
Footnotes (1)
- [F1]Represents acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d).
Documents
Issuer
Vistagen Therapeutics, Inc.
CIK 0001411685
Entity typeother
Related Parties
1- filerCIK 0001998663
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 8:51 PM ET
- Size
- 4.9 KB